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CCsvi hypothesis as a breakthrough. what is the optimal process and timing to trans fer research findings into clinical practice? Patients understandably want quick transla tion of theory to practice, but practice should be well supported by evidence. so, what con stitutes adequate evidence? reports from a single research group seem an inadequate basis for changing practice, particularly when the practice entails possibly dangerous procedures. what is the role of the media and patient advocacy? in the case of the CCsvi hypothesis, the media drew attention to a new idea, but did their spotlight serve patient needs? should physicians err on the side of paternalism or patient autonomy in the face of patient demands for new tests and unproven procedures? For CCsvi, the risk of testing is, primarily, one of financial loss, but the risks attached to intravascular inter ventions are more serious. indeed, one death has occurred already. the issues raised above require further thought ful discourse. the most pressing matter, however, is whether the CCsvi hypo thesis will turn out to be correct. in a co ordinated response, the us national mul tiple sclerosis society and the Canadian mul tiple sclerosis society announced plans to fund seven independent studies in north america beginning in July 2010. 9 these studies, as well as others from investiga tors worldwide, will, in time, resolve the controversy. Treatment and Research, Department of Neurology, Neurological Institute, Cleveland Clinic, Mail Stop JJ36, Cleveland, OH 44195, USA. rudickr@ccf.org doi:10.1038/nrneurol.2010.117 Acknowledgments The author thanks J. Cohen, e. Fisher, R. Fox and R. Ransohoff for helpful comments on the manuscript, and C. Talerico for editorial assistance.
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Sedation and anesthesia during endovascular stroke therapy
Philip M. Meyers and Eric J. Heyer
A large, retrospective study indicates that in patients with acute ischemic stroke, endovascular interventions performed under conscious sedation carry a lower risk of poor neurological outcome and mortality than those performed under general anesthetic. owing to a number of potential confounding factors, however, the results must be interpreted with caution.
when an individual has a stroke-par ticularly an acute ischemic stroke-seconds count. every minute after the event, 1.9 million neurons, 830 billion synapses, and 714 km of myelinated fibers are esti mated to be destroyed. 1 early recognition of stroke signs and symptoms is important for timely entry into the emergency medical system. intra venous fibrinolysis using tissue plasmino gen activator is the first line of therapy for patients presenting to hospital within 4.5 h of stroke onset.
2 in recent years, however, considerable progress has also been made in developing endovascular thera pies that aim to reestablish blood flow in occluded cerebral arteries.
3,4 to enable these endovascular procedures to be performed, fluoroscopic (Xray) guidance is required. Patients are often unable to cooperate because of their strokes, and the procedures can be painful. moreover, acute ischemic stroke is a heterogenous disease, and con clusive evidence that these endovascular procedures are effective at improving patient outcomes has remained elusive to date.
in a study published in Stroke, abou Chebl and colleagues have endeavored to address the debate on the sedation that is used when performing endovascular inter ventions on patients with acute ischemic stroke.
5 they ask whether these procedures should be performed using conscious seda tion, which may require less time to initi ate than other approaches, or whether an anesthesiologist should provide general anesthesia with ventilator support, so as to improve pain control, patient immobiliza tion and fluoro scopic visualization. in a retrospective analysis of 980 patients, who were admitted to 12 unrelated us hospi tals between 2005 and 2009 with anterior cerebral circulation strokes due to large artery occlusions, the authors reach the fol lowing conclusion: patients treated under general anesthesia have a greater chance of poor neurological outcome (odds ratio [or] = 2.33, P <0.0001) and mortality (or = 1.68, P <0.0001) than those given conscious sedation. unfortunately, the study leaves unanswered many questions that are necessary to support this conclusion.
the researchers collected deidentified patient demographic data, niH stroke scale (niHss) scores, data on use of intra venous tissue plasminogen activator and general anesthesia, time to groin puncture (proce dure start time), location of cerebral artery occlusion, drugs and devices used to effect vessel recanalization, degree of vessel recanalization, time to recanalization, post procedural hemor rhage, and 90 day neuro logical outcomes. the numbers of patients treated at any given center during the 5 year period varied from 9 to 264. use of general anesthesia for these stroke procedures also varied dramatically from center to center, ranging from 0-100%. the authors' question is an important one, and a decision must be made about the use of general anesthesia in every stroke treatment newS & vIewS procedure. many of the new devices that are used for endovascular stroke treatment are quite substantial in size relative to the vessels requiring treatment. For instance, the most effective version of the Penumbra stroke system (Penumbra, inc., alameda, Ca, usa) requires use of a 0.054 in (1.37 mm) suction catheter in delicate cere bral arteries measuring 2-5 mm in diameter (Figure 1 ). this type of catheter is relatively supple, but its navigation can still result in vessel distortion, pain, and even vomit ing. owing to the tortuosity of the cerebral arteries, navigation can be challenging even under general anesthesia with excellent fluoroscopic visualization. nevertheless, if clinical stroke data do not support the use of general anesthesia, its use should be eschewed despite its technical benefits. the paper by abouChebl et al. speaks to the difficulties in answering many questions about the treatment of patients with ische mic stroke. Controlled and uniform data are still difficult to obtain. in their introduction, the authors posit that conscious sedation might reduce delays to endovascular treatment, although the relevant data presented in the tables in the paper do not clearly indicate that delays occurred when general anesthesia was used. nevertheless, the authors state in their discussion that "delays related to [general anesthesia] may still account for some of the differences in outcome. " Data analysis throughout the article com pares 'good outcome' versus 'poor outcome' , yet for the purposes of the paper and its con clusions a more logical comparison would include the method of anesthesia, namely, conscious sedation or general anesthesia. analysis of the anesthesia records would help define the anesthetics used, blood pres sure parameters, and other physio logical indicators of patient outcome to guide future therapy. unfortunately, these data were not collected. in all likelihood, the patients treated under general anesthesia in this study were moregravely ill or had moredifficult occlusions to revascularize than those who were treated under conscious sedation. multi variate analysis taking into account other measures of illness might have made the two anesthetic techniques more comparable in terms of overall outcomes. in summary, the present data are not strong enough to change practice, but the concept of conscious sedation versus general anesthesia will remain in mind and should be addressed in future stroke trials.
